Technical Analysis for 0QYQ - Gilead Sciences Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 65.47 | -0.77% | -0.51 |
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Very Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
New 52 Week Closing Low | Bearish | 0.00% | |
Reversal New Lows Setup | Bearish Swing Setup | 0.00% | |
Doji - Bullish? | Reversal | 0.00% | |
New 52 Week Low | Weakness | 0.00% | |
Earnings Movers | Other | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Gapped Down | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
New 52 Week Closing Low | Bearish | -0.77% | |
180 Bearish Setup | Bearish Swing Setup | -0.77% |
Get this analysis on your stocks daily!
Gilead Sciences Inc. Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Merck & Co, Inc., and Tentarix Biotherapeutics Inc., as well as a partnership with Assembly Biosciences, Inc. to develop next-generation therapeutics for serious viral diseases. The company was incorporated in 1987 and is headquartered in Foster City, California.
Classification
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 86.57 |
52 Week Low | 65.47 |
Average Volume | 381 |
200-Day Moving Average | 76.38 |
50-Day Moving Average | 71.30 |
20-Day Moving Average | 68.48 |
10-Day Moving Average | 66.79 |
Average True Range | 1.00 |
RSI (14) | 24.24 |
ADX | 50.84 |
+DI | 8.74 |
-DI | 34.11 |
Chandelier Exit (Long, 3 ATRs) | 70.39 |
Chandelier Exit (Short, 3 ATRs) | 68.46 |
Upper Bollinger Bands | 72.90 |
Lower Bollinger Band | 64.07 |
Percent B (%b) | 0.16 |
BandWidth | 12.89 |
MACD Line | -1.78 |
MACD Signal Line | -1.68 |
MACD Histogram | -0.0945 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 66.81 | ||||
Resistance 3 (R3) | 66.95 | 66.66 | 66.58 | ||
Resistance 2 (R2) | 66.66 | 66.32 | 66.58 | 66.51 | |
Resistance 1 (R1) | 66.06 | 66.11 | 65.92 | 65.92 | 66.43 |
Pivot Point | 65.77 | 65.77 | 65.69 | 65.69 | 65.77 |
Support 1 (S1) | 65.17 | 65.43 | 65.03 | 65.03 | 64.51 |
Support 2 (S2) | 64.88 | 65.22 | 64.80 | 64.43 | |
Support 3 (S3) | 64.28 | 64.88 | 64.36 | ||
Support 4 (S4) | 64.14 |